Transfer factor for injection

This drug is an immune enhancement drug. It is a polynucleotide peptide (molecular weight less than 5000) extracted from healthy human blood or animal spleen. It is not easily destroyed by RNAse, DNAse and trypsin. This drug is an important factor in cellular immune response. It has no antigenicity and is not an antibody fragment, but it can transmit the cellular immune reactivity of multiple antigens, including bacteria, fungi, viruses, tissue compatibility antigens and tumor-specific antigens, etc. It can enhance the immune reactivity of receptor cells, promote the chemotaxis of macrophages, increase delayed cell response, and improve the body's ability to kill tumors.

The main ingredients of this product are polypeptide and ribose (extracted from pig spleen); the auxiliary material is dextran.

This product is a colorless or slightly yellow loose body, which turns into a colorless or slightly yellow clear liquid after dissolution.

1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Subcutaneous injection: (preferably the inner side of the upper arm or the lower end of the inner thigh groin where lymphatic return is abundant, it can also be injected subcutaneously into the deltoid muscle of the upper arm), 1 to 2 injections at a time, once a week or two weeks or as directed by the doctor.

1. The most common adverse reactions are pain, nodules and systemic fever at the injection site. Some patients may develop urticaria-like rashes. 2. It has been reported that this drug has caused hemolytic anemia and lymphoma in the treatment of Wiskott-Aldrich Syndrome. 3. It has been reported that this drug can cause typical attacks of bronchial asthma.

Patients who are allergic to any component of this product.

If you are using other medicines, you should consult your physician or pharmacist before using this product.

Keep tightly closed in a cool, dark place.

3mg(peptide):100μg(ribose)

Youcare Pharmaceutical Group Co., Ltd.

• Founded in:

  2001-08-14

• Address:

  No. 6, Hongda Middle Road, Beijing Economic and Technological Development Zone, Beijing

• Tax NO.:

  911100007263731643

• Registered Funds:

  450 million yuan

• Website:

  Log in to view

• Email:

  Log in to view